Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer

Environmental Health Perspectives

Volumn 110, Issue 3, 2002, Pages 241-246

  Sauter, Edward R ^a   Tichansky, David S ^a   Chervoneva, Inna ^a   Diamandis, Eleftherios P ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast cancer; Nipple aspirate fluid; Prostate specific antigen; Sex hormones; Testosterone

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AGE; AGED; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; BLOOD ANALYSIS; BODY FLUID; BREAST CANCER; BREAST SURGERY; CANCER TISSUE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MENOPAUSE; NIPPLE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUMP; SENSITIVITY ANALYSIS; TESTOSTERONE BLOOD LEVEL; TISSUE LEVEL;

EID: 0036193923     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110241     Document Type: Article

References (38)

1. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland
2. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women
3. Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients
4. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women
5. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey
6. Re: Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women
7. Serum sex hormone levels are related to breast cancer risk in postmenopausal women
8. Serum sex hormone levels after menopause and subsequent breast cancer
9. Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast
10. Androgens in breast cancer. III. Breast cancer recurrences years after mastectomy and increased androgenic activity
11. Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women
12. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size
13. Prostate specific antigen-its usefulness in clinical medicine
14. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
15. Non-prostatic sources of prostate-specific antigen
16. New biological functions of prostate-specific antigen?
17. The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast
18. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk
19. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: Potential applications in prostate and breast cancers
20. Serum total and free prostate-specific antigen for breast cancer diagnosis in women
21. Prostate-specific antigen: Biochemistry, analytical methods, and clinical application
22. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer
23. Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines
24. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines
25. Expression of the prostate specific antigen gene by lung tissue
26. Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue
27. Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: An interphase cytogenetic study
28. Decreased apoptosis in non-involved tissue from cancer-containing breasts
29. HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer
30. p53 protein accumulation and mutations in normal and benign breast tissue
31. Morphological evidence for field effect as a mechanism for tumour spread in mammary Paget's disease
32. High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast
33. Transport of protein-bound hormones into tissue in vivo
34. A comparison of serum and breast duct fluid-immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease
35. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker
36. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts
37. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women
38. Potent carcinogenicity of 2,7-dinitrofluorene, an environmental pollutant, for the mammary gland of female Sprague-Dawley rats